Citations 82

Faculty Opinions recommendation of Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | July 31, 2012 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.13471974.14851081

Genes Associated with Recurrence of Hepatocellular Carcinoma: Integrated Analysis by Gene Expression and Methylation Profiling

Journal of Korean Medical Science | November 1, 2011 | Volume: 26 | Issue: 11 | Pages: 1428

10.3346/jkms.2011.26.11.1428 | PMID 22065898